Silver Book Fact

Stopping the Progress of Parkinson’s Would Save >$440,000 per Person

Fact image

An Economic Model of Parkinson’s Disease: Implications for slowing progression in the United States. Mov Disorders. 2013; 28(3). https://onlinelibrary.wiley.com/doi/abs/10.1002/mds.25328

Reference

Title
An Economic Model of Parkinson’s Disease: Implications for slowing progression in the United States
Publication
Mov Disorders
Publication Date
2013
Volume & Issue
Volume 28, Issue 3
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Donepezil, a new Alzheimer’s medication, increased prescription costs to $1,000 per patient, however the overall health care costs decreased from $11,947 to $8,056.  
  • Average Annual Direct Medical Costs Per Person with Parkinson’s Disease
     
  • A clinical trial in Europe found that treating Alzheimer’s patients with an Alzheimer’s drug reduced annual treatment costs by $1,000 per patient.  
  • Spinal Cord Stimulation Shows Improvements for Parkinson’s Patients
     
  • Stem Cell Therapy Study Shows Improved Motor Function in Parkinson’s